Release Date: 24/07/18 16:39 Summary: Noosa Acquisition Completed Price Sensitive: No Download Document 470.71KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%